Sankalp is a principal in the pharmaceutical practice and leads the cell and gene therapy (C>) vertical at ZS. He brings together interconnected solutions across biomedical research, supply chain, technology and commercialization to help accelerate and simplify the process of bringing innovative, transformative cell and gene therapies to market. Sankalp previously led the healthcare ecosystem space for ZS within oncology, helping manufacturers improve B2B capabilities and organization models to better support the integrated needs of their customers.
Sankalp spends a majority of his time helping C> organizations build their commercial infrastructure from brand strategy, customer engagement strategy, supply planning and organization design. He has more than twelve years of experience helping clients with strategic challenges across sales and marketing practices. Sankalp’s background is in oncology and over the last ten years, he has helped several clients commercialize oncology products. Sankalp has particular experience in go-to-market strategy, customer experience and sales transformation. He has supported oncology companies across a full spectrum of commercial challenges including pre-launch, launch and post-launch. Sankalp has partnered with two large pharmaceutical companies, bringing innovative cancer therapies to market and local emerging biotechnology companies in Boston, setting up their commercial infrastructure and capabilities to bring their first drugs to market.
Sankalp has extensive experience partnering with manufacturers in the cell and gene therapy space, helping organize their commercial infrastructure to bring these novel innovations to market.
Before joining ZS, Sankalp briefly worked in manufacturing and industrial engineering with a range of automobile and heavy engineering companies.
Sankalp received a bachelor’s degree from the University of Delhi in mechanical engineering and a master’s degree in engineering from the University of Wisconsin in Madison.